Overview

A Trial of SHR0410 Injection in Postsurgical Pain Management

Status:
Not yet recruiting
Trial end date:
2022-11-03
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the efficacy, safety of SHR0410 Injection and to explore the reasonable of SHR0410 Injection for Pain Management after Orthopaedic Surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.